{"id":"W4220909053","doi":"10.1038/s41586-022-04508-4","title":"Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer","year":2022,"lang":"en","type":"article","venue":"Nature","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Ipilimumab; Hazard ratio; Internal medicine; Chemotherapy; Oncology; Cancer; Gastroenterology; Randomized controlled trial; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001771937,0.0001475513,0.0002596012,0.0001336237,0.0001074753,0.00001092577,0.0001551554,0.0003217045,0.006382864],"category_scores_gemma":[0.00001076721,0.0001185225,0.0001064928,0.0005367594,0.00004130057,0.00004385479,0.00004189982,0.00210009,0.000004327736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008840174,"about_ca_system_score_gemma":0.0004761517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003404733,"about_ca_topic_score_gemma":0.0003434786,"domain_scores_codex":[0.9988227,0.00004222666,0.0001861265,0.0002788531,0.0003818652,0.0002881565],"domain_scores_gemma":[0.9995818,0.00002450056,0.00005887622,0.000249397,0.00002946726,0.00005599926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1483857,0.001399512,0.08815256,0.0003682558,0.0008311741,0.001979847,0.006522814,0.0002129526,0.05799733,0.0001340884,0.4092454,0.2847703],"study_design_scores_gemma":[0.04545497,0.001622496,0.1725729,0.0001493907,0.00006372012,0.0004141587,0.001425404,0.0005634452,0.005565998,0.00005396652,0.7716558,0.000457707],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9686766,0.01746687,0.000004357461,0.01032099,0.001060913,0.0006353707,0.00008374712,0.00009227142,0.001658838],"genre_scores_gemma":[0.9766322,0.0004647709,0.0001545238,0.0129179,0.0002865963,0.000138677,0.00003370937,0.00003509126,0.009336514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3624104,"threshold_uncertainty_score":0.9945254,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01058143885385141,"score_gpt":0.3003839206273684,"score_spread":0.289802481773517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}